KNSA vs TROW · P/E 53, rev $677.6M vs P/E 12, rev $3.76B
Kiniksa Pharmaceuticals Ltd (KNSA) versus T. Rowe Price Group Inc (TROW) — a side-by-side from cached financials, not a winner call.
Kiniksa Pharmaceuticals Ltd (KNSA) is a drug manufacturers - specialty & generic company listed on US.
T. Rowe Price Group Inc (TROW) is a asset management company listed on NASDAQ.
Latest reported KNSA revenue for 2025-12-31 was $677.6M. Net income was $59.0M. Revenue was up 60.1% from 2024-12-31 to 2025-12-31. KNSA currently screens at market cap $3.73B and trailing P/E 53.2.
Latest reported TROW revenue for 2026-06-30 was $3.76B. Net income was $1.13B. TROW currently screens at market cap $23.17B and trailing P/E 11.6.
KNSA currently screens at market cap $3.73B and trailing P/E 53.2. TROW currently screens at market cap $23.17B and trailing P/E 11.6.
Not investment advice. Open the KNSA and TROW stock pages for the full models.
Not investment advice.